Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roland Wolf

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Environmental Pollution (Barking, Essex : 1987)|November 20, 2020
Application of the in vivo oxidative stress reporter Hmox1 as mechanistic biomarker of arsenic toxicityFrancisco Inesta-Vaquera, Panida Navasumrit, Colin J Henderson, et al.
Molecular Pharmacology|October 27, 2018
Constitutive androstane receptor 1 is constitutively bound to chromatin and 'primed' for transactivation in hepatocytesMichael McMahon, Shaohong Ding, Lourdes Acosta Jimenez, et al.
International Journal of Cancer|September 8, 2004
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancerFaye Turner, Gillian Smith, Christoph Sachse, et al.
Lancet (London, England)|April 25, 2003
Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseasesGillian Smith, C Roland Wolf, Yusuf Y Deeni, et al.
PPAR Research|May 3, 2012
Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In VivoLarry G Higgins, Wojciech G Garbacz, Mattias C U Gustafsson, et al.
The Journal of Biological Chemistry|March 21, 2003
Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase PiRobert Elsby, Neil R Kitteringham, Christopher E Goldring, et al.
British Journal of Cancer|November 9, 2016
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancerA Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip J Coates, et al.
Toxicology and Applied Pharmacology|November 3, 2007
Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouseMarie Stiborová, Volker M Arlt, Colin J Henderson, et al.
The Journal of Biological Chemistry|November 26, 2002
Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6Mark J I Paine, Lesley A McLaughlin, Jack U Flanagan, et al.
Biochemical Pharmacology|January 18, 2005
Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2Kevin J Spears, Jillian Ross, Alasdair Stenhouse, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Environmental Pollution (Barking, Essex : 1987)|November 20, 2020
Application of the in vivo oxidative stress reporter Hmox1 as mechanistic biomarker of arsenic toxicityFrancisco Inesta-Vaquera, Panida Navasumrit, Colin J Henderson, et al.
Molecular Pharmacology|October 27, 2018
Constitutive androstane receptor 1 is constitutively bound to chromatin and 'primed' for transactivation in hepatocytesMichael McMahon, Shaohong Ding, Lourdes Acosta Jimenez, et al.
International Journal of Cancer|September 8, 2004
Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancerFaye Turner, Gillian Smith, Christoph Sachse, et al.
Lancet (London, England)|April 25, 2003
Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseasesGillian Smith, C Roland Wolf, Yusuf Y Deeni, et al.
PPAR Research|May 3, 2012
Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In VivoLarry G Higgins, Wojciech G Garbacz, Mattias C U Gustafsson, et al.
The Journal of Biological Chemistry|March 21, 2003
Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase PiRobert Elsby, Neil R Kitteringham, Christopher E Goldring, et al.
British Journal of Cancer|November 9, 2016
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancerA Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip J Coates, et al.
Toxicology and Applied Pharmacology|November 3, 2007
Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouseMarie Stiborová, Volker M Arlt, Colin J Henderson, et al.
The Journal of Biological Chemistry|November 26, 2002
Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6Mark J I Paine, Lesley A McLaughlin, Jack U Flanagan, et al.
Biochemical Pharmacology|January 18, 2005
Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2Kevin J Spears, Jillian Ross, Alasdair Stenhouse, et al.
Pageof 16